1 / 2

CMV Management Strategies: Efficacy and Reduction Outcomes

Explore the effectiveness of universal vs. preemptive anti-CMV strategies in reducing disease rates and organ complications. Learn from Kalil AC et al.'s study comparing various antiviral medications.

Download Presentation

CMV Management Strategies: Efficacy and Reduction Outcomes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Percent reduction with the universal vs preemptive anti-CMV strategy relative to placebo or no therapy Kalil AC et al. Ann Intern Med 2005; 143:870-880.

  2. Percent reduction in CMV organ disease vs controls with different antiviral medications Kalil AC et al. Ann Intern Med 2005; 143:870-880.

More Related